---
layout: post
title: "诺和诺德盘前涨1.4% 料糖尿病药物Ozempic二季度在美上市"
date: 2022-03-30 16:46:41 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/106.NVO" data-code="NVO|106|7" data-code2="NVO|106|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=106.NVO&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 NVO_0" data-code="K NVO|106|7" data-code2="K NVO|106|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>诺和诺德(NVO.US)盘前涨1.4%，报111.73美元。消息称，诺和诺德旗下2毫克剂量的2型糖尿病药物Ozempic获美国食品药品监督管理局(FDA)批准。公司预计将于第二季度在美国推出2毫克剂量的Ozempic. </p>
 <center><img src="https://dfscdn.dfcfw.com/download/D24802312322541996364_w519h404.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203302328263216>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)